Wadden TA, Chao AM, Moore M, Tronieri JS, Gilden A, Amaro A, et al. The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities. Curr Obes Rep. 2023;12:453–73. https://doi.org/10.1007/s13679-023-00534-z.

Article  PubMed  PubMed Central  Google Scholar 

Beutler LR. GLP-1 physiology and pharmacology along the gut-brain axis. J Clin Invest. 2026;136:e194744. https://doi.org/10.1172/JCI194744.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chao AM, Taylor S, Moore M, Amaro A, Wadden TA. Evolving Approaches for Pharmacological Therapy of Obesity. Annu Rev Pharmacol Toxicol. 2025;65:169–89. https://doi.org/10.1146/annurev-pharmtox-031124-101146.

Article  CAS  PubMed  Google Scholar 

Kushner RF, Batsis JA, Butsch WS, Davis N, Golden A, Halperin F, et al. Weight History in Clinical Practice: The State of the Science and Future Directions. Obesity. 2020;28:9–17. https://doi.org/10.1002/oby.22642.

Article  PubMed  Google Scholar 

Pope HG, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement. Endocr Rev. 2014;35:341–75. https://doi.org/10.1210/er.2013-1058.

Article  CAS  PubMed  Google Scholar 

Propfe LE, Seifert R. Misrepresentation of semaglutide in social media. Naunyn Schmiedebergs Arch Pharmacol. 2026;399:815–32. https://doi.org/10.1007/s00210-025-04403-5.

Article  CAS  PubMed  Google Scholar 

Laughter MR, Anderson JB, Maymone MBC, Kroumpouzos G. Psychology of aesthetics: Beauty, social media, and body dysmorphic disorder. Clin Dermatol. 2023;41:28–32. https://doi.org/10.1016/j.clindermatol.2023.03.002.

Article  PubMed  Google Scholar 

Collins S. The Beta-Adrenergic Receptors and the Control of Adipose Tissue Metabolism and Thermogenesis. Recent Prog Horm Res. 2001;56:309–28. https://doi.org/10.1210/rp.56.1.309.

Article  CAS  PubMed  Google Scholar 

Holm C, Østerlund T, Laurell H, Contreras JA. Molecular Mechanisms Regulating Hormone-Sensitive Lipase and Lipolysis. Annu Rev Nutr. 2000;20:365–93. https://doi.org/10.1146/annurev.nutr.20.1.365.

Article  CAS  PubMed  Google Scholar 

Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK, et al. Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. J Clin Endocrinol Metab. 2024;110:1–15. https://doi.org/10.1210/clinem/dgae719.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin W-Y, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331:38. https://doi.org/10.1001/jama.2023.24945.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28:2083–91. https://doi.org/10.1038/s41591-022-02026-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989–1002. https://doi.org/10.1056/NEJMoa2032183.

Article  CAS  PubMed  Google Scholar 

Kaneto H, Kimura T, Obata A, Shimoda M, Kaku K. Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History. Int J Mol Sci. 2021;22:2596. https://doi.org/10.3390/ijms22052596.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mantri S, Agarwal S, Jaiswal A, Yelne S, Prasad R, Wanjari MB, Bodybuilding. A Comprehensive Review of Performance-Enhancing Substance Use and Public Health Implications. Cureus. 2023 https://doi.org/10.7759/cureus.41600. [cited 2026 Apr 2].

Ostovar A, Haerinejad MJ, Farzaneh MR, Keshavarz M. Adverse effects of performance-enhancing drugs on the kidney in the male bodybuilders. Sci Sports. 2017;32:91–8. https://doi.org/10.1016/j.scispo.2016.12.001.

Article  Google Scholar 

Manning P. There’s no glamour in glue: News and the symbolic framing of substance misuse. Crime Media Cult Int J. 2006;2:49–66. https://doi.org/10.1177/1741659006061711.

Article  Google Scholar 

Yalçın N, Armut M, Kelleci Çakır B, Demirkan K. Drug-induced nutritional disorders. Clin Sci Nutr. 2020;1:113–22. https://doi.org/10.5152/ClinSciNutr.2020.962.

Article  Google Scholar 

Desgorces FD, Moinard C, Chennaoui M, Toussaint J-F, Petibois C, Noirez P. Development of a specific index to detect malnutrition in athletes: Validity in weight class or intermittent fasted athletes. Biochim Open. 2017;4:1–7. https://doi.org/10.1016/j.biopen.2016.10.001.

Article  PubMed  Google Scholar 

Silva JE, Bianco SDC. Thyroid–Adrenergic Interactions: Physiological and Clinical Implications. Thyroid. 2008;18:157–65. https://doi.org/10.1089/thy.2007.0252.

Article  CAS  PubMed  Google Scholar 

Konopka AR, Laurin JL, Schoenberg HM, Reid JJ, Castor WM, Wolff CA, et al. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell. 2019;18:e12880. https://doi.org/10.1111/acel.12880.

Article  CAS  PubMed  Google Scholar 

Murray S, Tulloch A, Gold MS, Avena NM. Hormonal and neural mechanisms of food reward, eating behaviour and obesity. Nat Rev Endocrinol. 2014;10:540–52. https://doi.org/10.1038/nrendo.2014.91.

Article  CAS  PubMed  Google Scholar 

Lutter M, Nestler EJ. Homeostatic and Hedonic Signals Interact in the Regulation of Food Intake. J Nutr. 2009;139:629–32. https://doi.org/10.3945/jn.108.097618.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalender A, Selvaraj A, Kim SY, Gulati P, Brûlé S, Viollet B, et al. Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner. Cell Metab. 2010;11:390–401. https://doi.org/10.1016/j.cmet.2010.03.014.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walton RG, Dungan CM, Long DE, Tuggle SC, Kosmac K, Peck BD, et al. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo‐controlled, multicenter trial: The MASTERS trial. Aging Cell. 2019;18:e13039. https://doi.org/10.1111/acel.13039.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hostrup M, Reitelseder S, Jessen S, Kalsen A, Nyberg M, Egelund J, et al. Beta2 -adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men. J Physiol. 2018;596:4121–39. https://doi.org/10.1113/JP275560.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stojakovic A, Espinosa EP, Farhad OT, Lutfy K. Effects of nicotine on homeostatic and hedonic components of food intake. J Endocrinol. 2017;235:R13–31. https://doi.org/10.1530/JOE-17-0166.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bella YF, Cupido SRS, Inacio PAQ, Sobral MLP, Vieira RP. Pre-Workout Supplements and Their Effects on Cardiovascular Health: An Integrative Review. J Cardiovasc Dev Dis. 2025;12:112. https://doi.org/10.3390/jcdd12040112.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al. Nutritional priorities to support GLP -1 therapy for obesity: A joint Advisory from the American College of Lifesty